RxDoctor Payments Data

Marc Ernstoff

Medical Oncology · Frederick, MDNPI 1275549073

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,547 of the $14,472 with a category attached, or 93.6%. 3 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 49.8% of the total.

$14,472in general payments, 2019–2025

Across 14 payments — averaging $1033.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$7K
  • Alkermes, Inc.$7K
  • Clinigen, Inc.$290
$965,530in research payments, 2019–2025

Across 107 payments — averaging $9023.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$948K
  • E.r. Squibb & Sons, L.L.C.$17K
  • Merck$615

What the payments were for

  • Consulting fees$13,54794%
  • Travel & lodging$3122%
  • Food & beverage$6134%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.9$7,207
Alkermes, Inc.3$6,975
Clinigen, Inc.2$290

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,472 in reported general payments places this provider in the 65th percentile of 180 medical oncology providers in Maryland.

See all medical oncology providers in Maryland

Other medical oncology in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →